152932-57-5

Basic information

• Product Name: 2-Furancarboxaldehyde, 5-(difluoromethyl)- (9CI)
• Synonyms: 2-Furancarboxaldehyde, 5-(difluoromethyl)- (9CI)
• CAS NO: 152932-57-5
• Molecular Formula: C6H4F2O2
• Molecular Weight: 146.0915664
• Product Categories: ALDEHYDE
• Mol File: 152932-57-5.mol

Chemical Properties

• Boiling Point: 164.7±40.0 °C(Predicted)
• Appearance: /
• Density: 1.306±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 2-Furancarboxaldehyde, 5-(difluoromethyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Furancarboxaldehyde, 5-(difluoromethyl)- (9CI)(152932-57-5)
• EPA Substance Registry System: 2-Furancarboxaldehyde, 5-(difluoromethyl)- (9CI)(152932-57-5)

Safety Data

• Hazardous Substances Data: 152932-57-5(Hazardous Substances Data)

Upstream product

• 10049-21-5 sodium dihydrogenphosphate 
• 79-37-8 oxalyl dichloride 
• 67-68-5 dimethyl sulfoxide 
• 2689-65-8 5-iodofuran-2-carbaldehyde 

Relevant articles and documents

Direct Difluoromethylation of Aryl Halides via Base Metal Catalysis at Room Temperature

A stable and isolable difluoromethyl zinc reagent has been prepared through the reaction of ICF2H with diethyl zinc and DMPU. This new zinc reagent is a free-flowing solid and can be used in combination with a nickel catalyst to difluoromethylate aryl iodides, bromides, and triflates at room temperature. Such mild conditions for the catalytic difluoromethylation of these substrates are unprecedented.

THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS

Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula (IA).

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

Esters of 2,2-dimethyl-3-[(2,2-difluoro-cyclopropylidene) methyl]cyclopropane carboxylic acids

A compound selected from the group consisting of all stereoisomeric forms and mixtures thereof of a compound of the formula STR1 wherein Y and Z are individually selected from the groups consisting of hydrogen, halogen, --CF3, alkyl, alkoxy and alkylthio of 1 to 8 carbon atoms and aryl, aryloxy and arylthio of up to 14 carbon atoms optionally substituted with at least one member of the group consisting of halogen, hydroxy optionally esterified etherified, --CF3 and alkyl of 1 to 8 carbon atoms and R is alkyl of 1 to 8 carbon atoms or the remainder of a pyrethrinoid alcohol having excellent pesticidal properties and their preparation and intermediates.